Search results for: 'purotoxin 1'
- BA9262 PCO371Summary: PCO371 is an orally available complete inhibitor of parathyroid hormone receptor 1.
- R1003 EZ Cap™ EGFP mRNA (m1Ψ)Summary: EGFP mRNA with Cap 1 structure, modified by m1Ψ,providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- A4529 JW 55Summary: PARP domain inhibitor
- R1017 EZ Cap™ mCherry mRNA (5mCTP, ψUTP)Summary: mCherry mRNA with Cap 1 structure, modified by 5mCTP/ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: IGF-1R/InsR inhibitor,potent and selective
- R1036 EZ Cap™ Fdx1 mRNA (ψUTP)Summary: Fdx1 mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1037 EZ Cap™ Fdx1 mRNA (5-moUTP)Summary: Fdx1 mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1048 EZ Cap™ OVA mRNA (m1Ψ)Summary: Ovalbumin mRNA with Cap 1 structure, modified by m1Ψ, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation
- R1004 EZ Cap™ Firefly Luciferase mRNA (m1Ψ)Summary: Firefly Luciferase mRNA with Cap 1 structure, modified by m1Ψ,providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1028 EZ Cap™ OVA mRNA (5-moUTP)Summary: Ovalbumin mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation